Market Value1,351,367,000
Total Holdings58
File Date2018-08-14
Original Filing (Click here)

All hedge funds or institutions that manage over $100M are required by the SEC to file quarterly reports on their holdings. These reports are called 13F reports. However, the filings are required the following quarter from the reporting period, which means that by the time the filing is made (and we see them), the information could be five months old.

For funds with long term positions that make few trades, the holdings might closely resemble their current holdings, even after several months. However, for funds that have high turnover, the holdings data we see might differ significantly from their current holdings. Institutions are required to report CALL and PUT options, and those positions are identified in the table. However, they are not required to report short positions.

Click the link icon to see the full transaction history.

Upgrade to unlock premium data and export to Excel .

Security Imputed
Share Price
Prev
Shares
Current
Shares
Change
(Percent)
Prev Value
(USD x1000)
Current Value
(USD x1000)
Change
(Percent)
PTGX / Protagonist Therapeutics, Inc.
GEMP / Gemphire Therapeutics Inc.
ZLAB / Zai Lab Limited - Depositary Receipt (Common Stock)
ASND / Ascendis Pharma A/S - Depositary Receipt (Common Stock)
US62857M1053 / MyoKardia, Inc.
NKTR / Nektar Therapeutics
NKTR / Nektar Therapeutics Call
ITRM / Iterum Therapeutics plc
INSP / Inspire Medical Systems, Inc.
NERV / Minerva Neurosciences, Inc.
CLRBW / Cellectar Biosciences, Inc. Warrants expiring 8/20/2019
TSRO / TESARO, Inc.
ONSIZ / Oncobiologics, Inc. Series B Warrant Expiring 5/18
QTRX / Quanterix Corporation
ONSIW / Oncobiologics, Inc. Series A Warrant Expiring 2/18/2018
EOLS / Evolus, Inc.
BOLD / Boundless Bio, Inc.
IL0011177958 / Intec Pharma Ltd
VNDA / Vanda Pharmaceuticals Inc.
US28249H1041 / Eidos Therapeutics, Inc.
TBIO / Telesis Bio, Inc.
AVRO / AVROBIO, Inc.
GTHX / G1 Therapeutics, Inc.
ACRS / Aclaris Therapeutics, Inc.
SPPI / Spectrum Pharmaceuticals, Inc.
TCDA / Tricida Inc
KDMN / Kadmon Holdings Inc
DRNA / Dicerna Pharmaceuticals Inc
JNCE / Jounce Therapeutics Inc
TRIL / Trillium Therapeutics Inc
AVXS / AveXis, Inc.
ARNA / Arena Pharmaceuticals Inc
INCY / Incyte Corporation
KZR / Kezar Life Sciences, Inc.
VYNE / VYNE Therapeutics Inc.
CFRX / ContraFect Corp
SRRK / Scholar Rock Holding Corporation
IFRX / InflaRx N.V.
AUTL / Autolus Therapeutics plc - Depositary Receipt (Common Stock)
BPMC / Blueprint Medicines Corporation
RETA / Reata Pharmaceuticals Inc - Class A
SAGE / Sage Therapeutics, Inc.
CLSD / Clearside Biomedical, Inc.
TBPH / Theravance Biopharma, Inc.
COLL / Collegium Pharmaceutical, Inc.
/ Array BioPharma, Inc.
KNSA / Kiniksa Pharmaceuticals, Ltd.
NBIX / Neurocrine Biosciences, Inc.
QTNT / Quotient Ltd
ANAB / AnaptysBio, Inc.
ANAB / AnaptysBio, Inc. Call
BHVN / Biohaven Ltd.
OMER / Omeros Corporation
OMER / Omeros Corporation Call
XLRN / Acceleron Pharma Inc
SLDB / Solid Biosciences Inc.
MRNS / Marinus Pharmaceuticals, Inc.
HRTX / Heron Therapeutics, Inc.
SGMO / Sangamo Therapeutics, Inc.
MRTX / Mirati Therapeutics, Inc.
ARGX / argenx SE - Depositary Receipt (Common Stock)
ABEO / Abeona Therapeutics Inc.
MGTX / MeiraGTx Holdings plc
RCKT / Rocket Pharmaceuticals, Inc.
APLS / Apellis Pharmaceuticals, Inc.